Company / FCF Margin
CRESCENT BIOPHARMA, INC. FCF Margin History
FY2014-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest FCF Margin
-668.1%
FY2025
5-year range
-668.1% / -29.9%
FY2021-FY2025
Trend
-1475.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
FCF Margin changed -1476% YoY in FY2025, a notable deviation from the 4-year average annual change of -470%.
Based on SEC 10-K filings.
-668.1% in FY2025 with a 10-year CAGR of -276.9%.
Declined from -29.9% to -668.1% over the past 9 years.
FCF Margin over time
Growth rates
- 3-Year Change
- -
- 5-Year Change
- -
- 10-Year Change
- -276.9pp
Key checks
Key Insights
- In FY2025, fcf margin decreased 1475.8% year-over-year.
- Peak fcf margin was recorded in FY2016.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 0.35 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | FCF MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -668.1% | -1475.8% |
| FY2017 | -42.4% | -41.8% |
| FY2016 | -29.9% | +92.4% |
| FY2015 | -391.3% | -453.2% |
| FY2014 | -70.7% | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026